Life Sciences companies used to wait until commercialization to build out Sales and Marketing leadership. Not anymore. Today, CEOs and Investors are hiring commercial leaders earlier — often pre-revenue — to shape the strategy and drive valuation. Here’s why that shift is accelerating.
The Life Sciences market has shifted — and so has the commercial leadership playbook. In this environment of economic uncertainty and longer sales cycles, great CCOs and VPs of Sales are adapting fast. Here's what they’re doing differently — and why it matters to CEOs and Investors.
